文献速递母胎医学产科

胎儿肝内静脉输血术治疗胎儿贫血的可行性与安全性

[Feasibility and safety of fetal intravascular transfusion via the intrahepatic vein in the treatment of fetal anemia].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2021-01-01

该回顾性分析纳入2010至2019年上海一妇婴48例胎儿贫血患儿的97例次宫内输血,比较肝内静脉与脐静脉两种输血途径。两组活产率及穿刺成功率无显著差异,肝内静脉组术后并发症发生率不高,结论认为肝内静脉输血安全可行但技术要求较高。

要点

  • 肝内静脉输血组与脐静脉输血组活产率分别为13/16和75%(24/32),差异无统计学意义。
  • 两组穿刺成功率均为100%,脐静脉组针滑脱率5%、胎心异常率11%,肝内静脉组分别为0和3%。
  • 肝内静脉输血安全可行,但技术要求高,建议在有经验的胎儿治疗中心开展。

核心结论

  • 胎儿肝内静脉输血术治疗胎儿贫血安全可行,但对穿刺技术及胎儿体位要求较高,建议在有经验的胎儿治疗中心进行。

研究设计与样本

  • 回顾性分析2010年1月至2019年12月同济大学附属第一妇婴保健院48例贫血胎儿的97例次宫内输血,按输血途径分为肝内静脉输血组16例(31例次)和脐静脉输血组32例(66例次)。

主要发现

  • 两组孕妇年龄、分娩史及首次输血前胎儿水肿比例差异均无统计学意义(P均>0.05)。
  • 肝内静脉输血组后壁或侧壁胎盘占14/16,明显高于脐静脉输血组的78%(25/32,P<0.01)。
  • 肝内静脉输血组和脐静脉输血组活产率分别为13/16和75%(24/32),差异无统计学意义(P>0.05)。
  • 肝内静脉输血组输血术前胎儿水肿比例显著高于脐静脉输血组[55%(17/31) vs 24%(16/66),P<0.05]。
  • 两组穿刺成功率均为100%;脐静脉组针滑脱率5%(3/66)、一过性胎心率异常11%(7/66),肝内静脉组分别为0和3%(1/31),差异均无统计学意义(P均>0.05)。

临床怎么用

  • 肝内静脉途径可作为胎儿贫血宫内输血的备选通路,尤其适用于后壁或侧壁胎盘等特定情况。
  • 操作者需具备较高穿刺技术,并建议在有经验的胎儿治疗中心开展。

局限性

  • 本研究为单中心回顾性分析,样本量较小(48例胎儿、97例次输血),组间比较可能受选择偏倚影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the feasibility and safety of fetal intravascular transfusion via the intrahepatic vein in the treatment of fetal anemia. Methods: This was a retrospective analysis of all fetuses requiring intrauterine transfusion (IUT) in the Shanghai First Maternity and Infant Hospital between January 2010 and December 2019. According to the different ways of IUT, they were divided into intrahepatic venous transfusion group and umbilical venous transfusion group, fetal outcomes and the incidence of procedure-related complications between the two groups were compared. Results: A total of 97 IUTs were performed on 48 fetuses. Among them, 16 cases were performed in the intrahepatic vein (31 transfusions), 32 cases were performed in the cord of the umbilical vein (66 transfusions).There were no significant differences between the two groups in age, labor history and the proportion of fetal hydrops before the first transfusion. In the intrahepatic venous transfusion group, the posterior placenta was 14/16, which was significantly higher than 78% (25/32) in the umbilical venous transfusion group (P<0.01). The live-birth rates of the two groups were 13/16 and 75% (24/32). There was no significant difference between the two groups (P>0.05). Before intrahepatic venous transfusion, the proportion of fetal hydrops was significantly higher than that of umbilical venous transfusion [55% (17/31) vs 24% (16/66), P<0.05]. Puncture success rate of intrahepatic venous transfusion and umbilical venous transfusion were both 100%. In the umbilical venous transfasion group, the incidence of needle slippage (5%, 3/66) and the abnormality of fetal heart rate (11%, 7/66) were higher than those in the intrahepatic venous transfasion group [0 and 3% (1/31)], but there were no significant differences between the two groups (all P>0.05). There were no cases of fetal loss within 24 hours, premature rupture of membranes, infection within 7 days and emergency cesarean section after IUT in both groups. Conclusions: Fetal intravascular transfusion via the intrahepatic vein is safe and feasible in the treatment of fetal anemia. But the requirements of puncture technique are relatively high, so it is recommended to be carried out in experienced fetal treatment center. 目的: 探讨胎儿肝内静脉输血术在胎儿贫血宫内输血中的可行性及安全性。 方法: 对2010年1月至2019年12月在同济大学附属第一妇婴保健院诊治及分娩的胎儿贫血患儿的临床资料进行回顾性分析,将治疗过程中单一输血途径的胎儿按输血途径的不同,分为肝内静脉输血组和脐静脉输血组,比较两组胎儿结局及操作相关并发症的发生情况。 结果: 48例贫血胎儿共行宫内输血术97例次,其中肝内静脉输血组16例(31例次),脐静脉输血组32例(66例次)。两组孕妇的年龄、分娩史等一般情况及首次输血前胎儿水肿比例分别比较,差异均无统计学意义(P均>0.05)。肝内静脉输血组后壁或侧壁胎盘占14/16,明显高于脐静脉输血组的78%(25/32,P<0.01)。肝内静脉输血组和脐静脉输血组的活产率分别为13/16和75%(24/32),两组比较,差异无统计学意义(P>0.05)。肝内静脉输血组输血术前胎儿水肿比例显著高于脐静脉输血组[分别为55%(17/31)和24%(16/66),P<0.05]。肝内静脉输血组和脐静脉输血组的穿刺成功率均为100%。脐静脉输血组的穿刺针滑脱率(5%,3/66)、一过性胎心率异常(11%,7/66)的发生率均高于肝内静脉输血组[分别为0和3%(1/31)],但两组分别比较,差异均无统计学意义(P均>0.05)。两组均无术后24 h内胎儿丢失、术后7 d内胎膜早破、感染及紧急剖宫产术等其他操作相关并发症的发生。 结论: 胎儿肝内静脉输血术对于治疗胎儿贫血是一种安全可行的方法,但对术者穿刺技术及胎儿体位要求相对较高,建议在有经验的胎儿治疗中心进行。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang YJ, Wei X, Zou G, et al. [Feasibility and safety of fetal intravascular transfusion via the intrahepatic vein in the treatment of fetal anemia]. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 33902235. doi:10.3760/cma.j.cn112141-20201026-00798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。